Skip to content

Information for HSRPP 2023 presenters

Poster presentation guidance

All posters should be prepared in portrait format and be A0 size. Lettering should be legible at two metres. Oversized posters will not be accepted for display.

  • Fixings for posters will be provided.
  • Presenters are responsible for printing their own poster.
  • All posters will be displayed for throughout the two days of the conference.
  • All poster presenters will present their posters (3 minutes) followed by questions (2 minutes) as part of a scheduled poster walk.
  • Presenters are advised to look at the RPS advice on “Preparing and presenting posters for conferences”.
  • There will be a prize for the best poster presentation at the conference.

All presenters must send a copy of their poster to [email protected] by noon on Friday 31 March 2023 in an email marked “POSTER Presentation ABSTRACT No. NN” in the subject line. This is to assist with poster judging.
Poster PDFs will be made available to delegates post conference. Please indicate in your submission email if you wish your poster to be excluded from this.

  • All poster presenters have already been invited to give a 1-minute summary advert (Rapid Fire presentation) for their poster. Presenters are allowed one slide only to tell delegates why your area of research is of interest/important and why they should view your poster.
  • The single slide should be produced using Microsoft PowerPoint and should be produced using the widescreen (16:9) layout. Presenters are advised to use 22pt text size as a minimum and avoid similar colour shades for example yellow text on a white background/blue text on a black background. There is only a maximum of one minute so keep it to the essential including your name and poster number!
  • Your slide should not be a simple repetition of your poster.

All presenters must send a copy of their Rapid Fire presentation slide to [email protected] by noon on Friday 31 March 2023 in an email marked “Rapid Fire Presentation ABSTRACT No. NN” in the subject line. It will be assumed that presenters who do not submit a Rapid Fire presentation slide by this deadline do not wish to take up the opportunity.

Abstract numbers for poster presentations

Abstract Number Submitter Institution Title
490 Abdulhakeem Ikolaba, Fatima Salawu The University of Manchester Patients' and Pharmacists' Experiences of a Community Pharmacy-Based Diabetes Care Plan
450 Akande-Sholabi, Wuraola University of Ibadan Barriers and Enablers to Medication Deprescribing among Older patients attending a Geriatric Clinic in Southwestern Nigeria: A Cross-Sectional Study
448 Al Hussain, Sarah Cardiff University Prescribing of oral antibacterial drugs in primary care out-of-hours services: a scoping review
438 Alageel, Nahla Queens University Belfast Patterns and appropriateness of prescribing for people with dementia in ambulatory care in Saudi Arabia: A cross-sectional study
492 Ali, Eman University of Bradford Anticholinergic burden in older people: descriptive analysis of the Community Ageing Research 75+ Study (CARE75+) cohort population
443 Alqahtani, Mubarak Queen's University Belfast Selection of Outcome Measurement Instruments for a Core Outcome Set for trials aimed at improving appropriate polypharmacy in older people in primary care
465 Alsulami, Nawaf QUB Medicines optimisation for residents with dementia during the COVID-19 pandemic: a qualitative study of the views and experiences of care home managers 
470 Bermingham, Margaret University College Cork Evaluation of cardiovascular risk factor control among people with diabetes in the community pharmacy setting – a cross sectional study
486 Bermingham, Margaret University College Cork Safety Culture in Irish Community Pharmacies: a cross-sectional study using the Community Pharmacy Survey on Patient Safety Culture
503 Burgin, Angela University of Bradford Barriers and facilitators to the development of pharmacy workforce digital skills– a qualitative study
499 Dalton, Kieran University College Cork Exploring intern doctors’ views and experiences of prescribing at hospital discharge: a qualitative interview study
508 David, Victoria University of Bradford Scoping the opportunity for pharmacogenomic testing for older people’s medicine optimisation in secondary care 
435 Feather, Calandra Imperial College NHS Healthcare Trust Indication documentation and indication-based prescribing within electronic prescribing systems: a systematic review and narrative synthesis of interventions that aid indication documentation
491 Fleming, Aoife University College Cork Anticholinergic cognitive burden score in a cohort of nursing home patients; an observational study.
459 Jethwa, Sneha University of Reading/ University Hospital Southampton NHS Trust Clinical Utility of Pharmacogenetic Tests When Prescribing Antidepressant Therapy for Depression, A Systematic Review and Meta-analysis of Randomised Controlled Trials.
460 Karim, Laura Robert Gordon University Integrating pharmacist independent prescribing in community pharmacy: investigating NHS Pharmacy First Plus using Normalization Process Theory
451 Lau, Wing Man Newcastle University A systematic review exploring cultural competence in pharmacy education
446 Lea, Natalie St Helens and Knowsley Teaching Hospitals NHS Trust A qualitative exploration using focus groups, of the perceived barriers and enablers if hospital pharmacists to participating in simulation based training
515 McCarthy, Ruth University College Cork Pharmacy Students’ Experiences of Discrimination during Experiential Learning Placement - a quantitative survey
495 Okeowo, Daniel University of Leeds Developing deprescribing resources for older people with polypharmacy living in primary care: using co-design and logic modelling
454 Raza, Amna University of Reading Exploring the views of care home staff on the use of antipsychotics for people with dementia amid the COVID-19 pandemic: A qualitative study
509 Scott, Sion University of Leicester Developing a Core Outcome Set for hospital deprescribing trials with older people under the care of a geriatrician
458 Tolley, Clare Newcastle University Medicines management of long-term conditions during the COVID19 pandemic: a narrative systematic review

Oral presentation guidance

  • Oral presentations will last 15 minutes followed by 5 minutes for questions and 5 minutes to move between rooms if needed.
    Presentations should be produced using Microsoft PowerPoint and should be produced using the widescreen (16:9) layout. Presenters are advised to use 22pt text size as a minimum and avoid similar colour shades for example yellow text on a white background/blue text on a black background.
  • All presenters must send a copy of their presentation to [email protected] by noon on Friday 31 March 2023 in an e-mail marked “ORAL Presentation ABSTRACT No. NN” in the subject line.
  • Presenters will not be able to bring their presentation to the conference on a memory stick.
  • Presentation slides (PDF) will be made available to delegates post conference. Please indicate in your submission email if you wish your slides to be excluded from this.
  • Presenters are strongly advised to practise their presentation in advance as timings will be strictly adhered to by session chairs to minimise disruption for delegates wishing to move between sessions.
  • There will be prizes for the best oral presentations at the conference.

Abstract numbers for oral presentations

Abstract Number Submitter Institution Title
441 Abdelaziz, Shahd Imperial College Healthcare NHS Trust Understanding the unintended consequences of new healthcare technologies aimed at supporting patient safety: a qualitative study
487 ALHASAN, HAMAD University of Reading Understanding the Medicines Labelling System in Kuwait’s Ibn Sina Hospital Using Work Domain Analysis.
453 Almomani, Hamzeh University of Reading Why Do People Buy Prescription Medicines Online? A Qualitative Interview Study
483 Bain, Amie Royal Wolverhampton NHS Trust A realist review of inpatient insulin self-administration policy interventions for people with diabetes in hospital
463 Berrou, ilhem University of the West of England Understanding the role of nurses in deprescribing medicines for older people: A systematic review
474 Chike-Obuekwe, Somto Univeristy of Huddersfield POTENTIAL CONTRIBUTION OF COMMUNITY PHARMACISTS IN SUICIDE PREVENTION IN NIGERIA: KEY INFORMANTS’ PERSPECTIVE
478 Cunningham, Scott Robert Gordon University A qualitative exploration of the implementation of the Prescribing course Designated Prescribing Practitioner role in community pharmacy
482 Daffu-O'Reilly, Amrit University of Bradford Developing a person-centred deprescribing process in primary care for older people living with frailty
500 Dalton, Kieran University College Cork General practitioners’ views on the electronic transfer of prescriptions to pharmacies in Ireland: a qualitative interview study
477 Dobia, Ali General Administration for Medical Services, MOI, Riyadh Twenty-Four-Hour Movement Practice Guidelines for Saudi Arabia using a modified RAND Appropriateness Method, and Evaluation (GRADE)-ADOLOPMENT approach: An Integration of Physical Activity, Sedentary Behaviour, and Sleep Duration
464 Gorton, Hayley University of Huddersfield Pharmacist and pharmacy students’ awareness and use of support resources for mental health: a cross-sectional survey
481 Hassan, Abrar Queen's University Belfast An exploration of general practice pharmacists’ (GPPs) views on their role in general practice: a cross-sectional questionnaire study
449 Heinrich, Clara H. University College Cork Multidisciplinary deprescribing review for frail older adults in long-term care: Development of a theory informed implementation strategy using a Delphi survey and Roundtable discussion with stakeholders.
445 Hurley, Eoin University College Cork GPs’ perceptions of pharmacists working in general practices in Ireland: a cross-sectional survey
506 Jani, Yogini Centre for Medicines Optimisation Research & Education Allergy Related Clinical Prescribing Alerts in an Electronic Health Record (EHR) System: a descriptive study
439 Kentab, Basma Queen's University Belfast Design and feasibility testing of IDC-VI: a theory-informed intervention to support medication dispensing and counselling for patients with vision impairment
488 Lewis, Penny The University of Manchester A qualitative study into the barriers and facilitators to effective communication with people with age-related hearing loss in community pharmacy settings
476 Medlinskiene, Kristina University of Bradford Prescribing of direct oral anticoagulants (DOACs) following a venous thromboembolism: a retrospective audit study
461 Merchant, Ellie Imperial College Healthcare NHS Trust Developing a Carer-Led Intervention Supporting older people and their carers with Medicines Management through pathways of care using interviews: a qualitative service evaluation
469 Nwanosike, Ezekwesiri University of Huddersfield Use of data-driven technology to optimise DOACs in morbidly obese patients
497 Okeowo, Daniel University of Leeds Patient perspectives of safe and routine deprescribing for older people living with polypharmacy: an interview study
444 Parsons, Carole School of Pharmacy, Queen’s University Belfast Readability, accessibility, quality, visual design and content of online information on dementia medication: a quantitative evaluation
475 Previdoli, Giorgia Bradford Institute of Health Research - Bradford Teaching Hospital Foundation Trust Co-designing an intervention to support safe medicines self-management for older people living with frailty and polypharmacy
456 Rabi, Ahmad Queen's University Belfast Urinary catheterisation in the nursing home setting: challenges and opportunities in catheter use and design: a questionnaire study.
502 Scannell, Mary Individual The effects of removing the requirement for prior reimbursement approval on anticoagulant use in Ireland: A cross sectional study. 
510 Scott, Sion University of Leicester Co-design of an evidence and theory-based hospital deprescribing behaviour change intervention
511 Scott, Sion University of Leicester Barriers and enablers to switching from a solid to a liquid formulation of Parkinson’s medication: A theory-based mixed methods investigation
513 Scott, Sion University of Leicester An international survey of practitioners to define the activities required to deliver safe deprescribing and their determinants
493 Wells, Joshua Kingston University A cross-sectional study to evaluate the validity of a novel patient-reported outcome measure of medication adherence in Chronic Obstructive Pulmonary Disease
498 Wells, Joshua Kingston University An observational cohort study to examine SPUR, a patient-reported outcome measure of medication adherence, as a predictor of admission and early readmission in patients living with Type 2 Diabetes